Loading...
•
Jun 30, 2024
Balchem Q2 2024 Earnings Report
Balchem delivered solid second quarter financials with record earnings from operations and adjusted EBITDA.
Key Takeaways
Balchem Corporation reported a 1.2% increase in net sales to $234.1 million for the second quarter of 2024. GAAP net earnings increased by 6.5% to $32.1 million, with earnings per share at $0.98. Adjusted EBITDA reached a record $62.3 million, a 5.0% increase from the prior year quarter. The Human Nutrition and Health and Specialty Products segments showed strong sales and earnings growth.
Net sales increased by 1.2% to $234.1 million compared to the prior year quarter.
Adjusted EBITDA reached a record $62.3 million, a 5.0% increase from the prior year quarter.
GAAP net earnings increased by 6.5% to $32.1 million, with earnings per share at $0.98.
Human Nutrition and Health and Specialty Products segments delivered strong sales and earnings growth.
Balchem
Balchem
Balchem Revenue by Segment
Revenue by Segment
Human Nutrition & Health Revenue
CapyFin.comAnimal Nutrition & Health Revenue
CapyFin.comSpecialty Products Revenue
CapyFin.com Forward Guidance
We are well positioned in the markets we serve and remain confident in the long-term growth outlook for our company as we continue to focus on progressing our strategic growth initiatives in 2024 and beyond.
Revenue & Expenses
Visualization of income flow from segment revenue to net income